LINDAL invests in US production line for Pinocchio nasal actuator

The LINDAL Group has invested in a new production line in North America for its nasal actuator, Pinocchio.
Installed at its Columbus facility in the US, the new line boosts the company’s capacity to meet rising market demand and offers valuable improved lead times for customers worldwide, according to the organisation.
Sales director at LINDAL North America, Arianna Chang, said: “Expanding our production capacity allows us to deliver more flexible lead times for our customers, which in turn, allows them to be more responsive to their own customers’ requirements.”
The Pinocchio nasal actuator is one of LINDAL’s most popular dispensing products.
Manufactured in mono material, it is available in both child and adult versions.
Pinocchio is supplied with a sterilisable over cap and is compatible with the company’s wide range of female valves and Bag-on-Valve (BoV) technology.
Chang added: “Pinocchio’s increased production capacity, coupled with the recent expansion of BoV manufacturing capabilities reinforces LINDAL’s commitment to serving our North American and global customers in this highly dynamic market segment.”